London & Capital Asset Management’s Repligen RGEN Stock Holding History

London & Capital Asset Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-54,956	Closed	-$6.84M	–	99
2025 Q2	$6.84M	Sell	54,956 -43,353	-44%	-$5.52M	0.52%	42
2025 Q1	$12.5M	Sell	98,309 -7,209	-7%	-$1.11M	1.07%	32
2024 Q4	$15.2M	Buy	105,518 +4,606	+5%	+$660K	1.29%	37
2024 Q3	$15M	Buy	100,912 +26,820	+36%	+$3.85M	1.19%	37
2024 Q2	$9.34M	Buy	74,092 +8,697	+13%	+$1.36M	0.79%	41
2024 Q1	$12M	Buy	65,395 +3,776	+6%	+$719K	0.92%	38
2023 Q4	$11.1M	Buy	61,619 +6,215	+11%	+$967K	0.93%	35
2023 Q3	$8.81M	Buy	+55,404	New	+$9.06M	0.8%	37

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

London & Capital Asset Management's RGEN Position: Q3 2025 in Review

London & Capital Asset Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 54,956 shares — an estimated $6.84M sold.

London & Capital Asset Management first reported a position in RGEN in Q3 2023 and held it in 8 quarters. The position peaked at $15.2M in Q4 2024. 452 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

London & Capital Asset Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
London & Capital Asset Management sold 54,956 Repligen shares in Q3 2025, an estimated $6.84M.
London & Capital Asset Management first reported a position in Repligen in Q3 2023 and held it in 8 quarters.
London & Capital Asset Management's Repligen position peaked at $15.2M in Q4 2024.
452 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on London & Capital Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.